Prediction of Outcomes in Patients With Chronic Heart Failure Based on Tissue Raman Spectroscopy

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

October 11, 2024

Study Completion Date

November 20, 2024

Conditions
Chronic Heart Failure
Interventions
DIAGNOSTIC_TEST

surface enhanced Raman Spectroscopy

"Spectral measurements of blood serum were performed on a silver nanoparticle substrate. Each 1.5 μL serum sample was applied to a substrate with a layer of silver nanoparticles and dried . The spectral characteristics of serum were analyzed using an experimental bench consisting of a spectrometric system and a microscope . The spectra were excited by laser module with a center wavelength of 785 nm. Each of the obtained spectra was a discrete set of 1700 parameters .~For skin Raman spectroscopy an experimental portable RS system was used, including a 785 nm diode laser , a portable commercially available Raman probe to filter the collected scattered radiation, and a portable spectrometer (QE65Pro, Ocean optics, Florida, USA). The scattered radiation was collected from the upper 1 to 2 mm thick skin layer. The Raman spectral range was 780-1000 nm with resolution of 0.2 nm. Each spectrum was recorded at an exposure time of 20 seconds with three-fold accumulation."

Trial Locations (1)

443099

city Samara hospital n.a. N.I.Pirogov, Samara

All Listed Sponsors
collaborator

City Clinical Hospital No.1 named after N.I. Pirogov

OTHER

lead

Samara State Medical University

OTHER